Trials / Completed
CompletedNCT06567392
A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male Volunteers
Phase I Clinical Trial of Mass Balance of [14C] HRS-5965 in Healthy Chinese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Chengdu Suncadia Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the Mass Balance of \[14C\] HRS-5965 in Healthy Adult Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C] HRS-5965 | Patients will receive single dose of orally \[14C\] HRS-5965 on Day 1. |
Timeline
- Start date
- 2024-09-03
- Primary completion
- 2024-10-08
- Completion
- 2024-10-08
- First posted
- 2024-08-22
- Last updated
- 2024-10-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06567392. Inclusion in this directory is not an endorsement.